Does amikacin treatment cause subclinical hearing loss in patients with cystic fibrosis?

INTRODUCTION: Aminoglycosides (AGs) have been widely used for potential life-threatening bacterial infections. Although AGs are well known for their ototoxic side effects, some AGs such as amikacin are considered less harmful to auditory functions; thus, auditory monitoring is mostly neglected durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Solmaz, Fevzi, Gündoğdu, Ercan, Akduman, Davut, Haksever, Mehmet, Dikici, Oğuzhan, Ünal, Fatih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615910/
https://www.ncbi.nlm.nih.gov/pubmed/28959562
http://dx.doi.org/10.1016/j.toxrep.2016.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615910/
https://www.ncbi.nlm.nih.gov/pubmed/28959562
http://dx.doi.org/10.1016/j.toxrep.2016.03.010

Ejemplares similares